Resistance Profile of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Abacavir (1592U89) after Monotherapy and Combination Therapy

s of the 2d International Workshop on HIV Drug Resistance and Treatment Strategies (Lake Maggiore, Italy). London: International Medical Press, 1998:36. 30. Mellors J, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70. 31. Condra JH. Virological and clinical implications of resistance to HIV-1 protease inhibitors. Drug Resistance Updates 1998; 1:292-9. This content downloaded from 157.55.39.231 on Thu, 06 Oct 2016 04:44:17 UTC All use subject to http://about.jstor.org/terms